Status:
UNKNOWN
BIOTRONIK - BIOFLOW-III Registry French Satellite
Lead Sponsor:
Biotronik France
Conditions:
Coronary Artery Diseases
Eligibility:
All Genders
18+ years
Brief Summary
For the majority of Coronary Artery Disease (CAD) treatment with Percutaneous Transluminal Coronary Angioplasty (PTCA) provides high initial procedure success. However, the medium to long-term complic...
Eligibility Criteria
Inclusion
- Symptomatic coronary artery disease
- Subject has signed informed consent for data release
- Subject is geographically stable and willing to participate at all follow up assessments
- Subject is ≥ 18 years of age
Exclusion
- Subject did not sign informed consent for data release
- Pregnancy
- Known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for PCI, stainless steel, Sirolimus or contrast media
Key Trial Info
Start Date :
November 19 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02273648
Start Date
November 19 2014
End Date
September 1 2021
Last Update
December 14 2017
Active Locations (50)
Enter a location and click search to find clinical trials sorted by distance.
1
CH d'Aix en Provence
Aix-en-Provence, France
2
Clinique de l'Europe
Amiens, France
3
Centre Hospitalier d'Antibes
Antibes, France
4
Clinique Rhône Durance
Avignon, France